Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Lamotrigine in Subjects With Absence Seizures

NCT00144872 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00144872
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00144872 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Lamotrigine in Subjects With Absence Seizures
Lead sponsor
GlaxoSmithKline
Phase
Phase 1
Overall status
Completed
Start date
November 1, 2004
Completion date
April 22, 2006
Enrollment
54 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

seizure, absence